menu

Cardiopulmonary Stress Testing Devices Market

Schedule Call

Cardiopulmonary Stress Testing Devices Market

Cardiopulmonary Stress Testing Devices Market by Product Type (CPET System, Stress ECG), End User (Hospitals, Specialty Clinics) – Global Outlook & Forecast 2022-2030

GR - 964744 Category: Medical Devices

Number of pages: 100  |  Report Format: PDF  |  Published date: 13 February, 2023

Historical Years – 2020  |  Base Year – 2021  |  Forecasted Years – 2022-2030


Cardiopulmonary Stress Testing Devices Market Scope

Report Attribute

Details

Market size value in 2021

US$ 5.52 billion

Revenue forecast in 2030

US$ 8.49 billion

Growth Rate

CAGR of 4.9% from 2022 to 2030

Base year for estimation

2021

Forecast period

2022-2030

Historical Year

2020

Segments covered

Product Type, End User, and Region

Regional scope

North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Report Overview

The global cardiopulmonary stress testing devices market was valued at US$ 5.52 billion in 2021. The market is expected to witness a CAGR of 4.9% during the forecast period from 2022 to 2030. 

Market Fundamentals

Cardiopulmonary stress testing devices are equipments used to evaluate the function of the heart and lungs during physical activity. These tests are used to diagnose and evaluate cardiovascular and pulmonary conditions of the heart, lung, and exercise-induced asthma. The test typically includes monitoring a person's heart rate, blood pressure, and breathing during exercise, typically on a treadmill or a stationary bike. The results of the test can indicate how well the heart and lungs respond to increased physical activity and can be used to determine a person's fitness level and identify any potential problems that need further evaluation or treatment.

The global cardiopulmonary stress testing devices market is expected to grow during the forecast period. This growth is driven by factors such as the aging population, increasing prevalence of chronic diseases like diabetes and a growing focus on preventative healthcare. According to American Heart Association, ischemic heart disease (IHD) affected around 244.1 million people worldwide in 2020. Males were more likely than females to have Ischemic heart disease, 141.0 and 103.1 million, respectively. Cardiopulmonary stress testing devices are preferred over invasive alternatives, such as catheterization, due to their ease of use and low risk of complications. The increase of healthcare expenditure and growing importance of preventative healthcare is also expected to drive the global cardiopulmonary stress testing devices growth. In addition, the growing number of clinical trials and research studies being conducted in the field of cardiopulmonary stress testing is also expected to contribute to the growth of the cardiopulmonary stress testing devices market. The demand for these devices is highest in the developed countries, due to the high prevalence of cardiovascular diseases and the availability of advanced diagnostic and treatment options. The high growth rate is expected in the emerging markets, due to the large population base, rising income levels, and increasing awareness about the benefits of early diagnosis and treatment of heart diseases. The key challenges in the cardiopulmonary stress testing devices market are the high cost of devices, the need for skilled professionals, and limited reimbursement.

[7546464]

Market Dynamics

According to the American Heart Association, around 19.1 million deaths were caused due to cardiovascular diseases in 2020 globally it the leading cause of death worldwide. The growing geriatric population is increasing the patients number and the rising demand for early diagnosis of cardiovascular disease is boosting the demand cardiopulmonary stress testing devices. The availability of advanced diagnostic and treatment with newer and more advanced devices with improved accuracy and ease of use are being developed which is propelling the growth of the cardiopulmonary stress testing devices market. Government agencies around the world are launching programs to increase public access to healthcare and raise public knowledge of health issues, which is helping the global cardiopulmonary stress testing devices market expand. Moreover, the soaring demand for point-of-care testing and non-invasive stress testing devices is expanding the growth of the cardiopulmonary stress testing devices market. Additionally, the growing sedentary lifestyle, increased consumption of Alcohol & tobacco, and increasing diabetes patients pool are fueling the growth of the global cardiopulmonary stress testing devices market. However, the high cost of the cardiopulmonary stress testing devices is the major restring factor of the cardiopulmonary stress testing devices market. The lack of killed healthcare professionals and limited reimbursement are also hindering the growth of the cardiopulmonary stress testing devices market. 

Market Ecosystem

The global cardiopulmonary stress testing devices market has been analyzed from three perspectives: Product Type, End User, and Region

Cardiopulmonary Stress Testing Devices Market by Product Type

[7463454]

Based on product type, the global cardiopulmonary stress testing devices market is segmented into cardiopulmonary exercise testing (CPET) systems, stress ECG, stress blood pressure monitors, pulse oximeters, and single-photon emission computed tomography (SPECT). The cardiopulmonary exercise testing (CPET) systems dominated the cardiopulmonary stress testing devices market in 2021. CPET systems are non-invasive which eliminates the risks associated with invasive testing methods. CPET systems provide a comprehensive evaluation of patients cardiovascular and pulmonary function by measuring multiple parameters, such as heart rate, blood pressure, and oxygen uptake thus increasing the demand CPET systems for the diagnosis of cardiovascular diseases. CPET systems allow for high-intensity testing, which simulates real-life activity and provides a more accurate assessment of a patient’s cardiovascular and pulmonary function. Moreover, CPET systems can be used to stratify risk in patients with heart failure, and chronic obstructive pulmonary disease.

Cardiopulmonary Stress Testing Devices Market by End User

Based on end-user, the global cardiopulmonary stress testing devices market is divided in hospitals, specialty clinics, diagnostic centers, and others. The hospitals segments had the largest market share in 2021. For the diagnosis and management of cardiovascular and pulmonary diseases hospitals are the primary healthcare providers. As a result, there is a high demand for cardiopulmonary stress testing devices in hospitals which is boosting the segmental growth. Hospitals have a large number of skilled healthcare professionals, such as cardiologists, pulmonologists, and other specialists, who are trained to use cardiopulmonary stress testing devices and interpret the results. This allows hospitals to provide accurate and reliable diagnostic and therapeutic services to patients. Moreover, Hospitals have advanced medical facilities that are equipped with the latest diagnostic and therapeutic technologies, including cardiopulmonary stress testing devices thus propelling the segment growth. 

Cardiopulmonary Stress Testing Devices Market by Region

Based on region, the global cardiopulmonary stress testing devices market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the global cardiopulmonary stress testing devices market in 2021, followed by Europe and Asia Pacific. The large share of North America is attributed to the rising prevalence of cardiovascular disease in the region. According to the Centers for Disease Control and Prevention (CDC), in 2020 around 697,000 people died due to cardiovascular diseases in U.S. The growing geriatric population in the region is increasing the incidence of cardiovascular disease, leading to a higher demand for cardiopulmonary stress testing devices. The government bodies in the region are providing fund for the R&D of devices for the cardiovascular disease diagnoses and the rising demand for early diagnosis of heart related diseases is boosting the regional growth. Additionally, the presences of major companies in the region is also anticipated to fuel regional growth. 

Competitive Landscape

Some of the prominent players operating in the cardiopulmonary stress testing devices market are: 

Strategic Developments

  • In January 2023, CAIRE Inc. finalized the acquisition of MGC Diagnostics Holdings, Inc. (MGC). Through this acquisition CAIRE will add MGC’s brand of non-invasive cardiorespiratory diagnostic systems, accessories, and consumables for the detection, classification, and management of cardiorespiratory disease in their product portfolio.
  • In February 2022, AliveCor launched the KardiaMobile Card, the slimmest, most convenient personal ECG device ever created. At the size of a standard credit card, KardiaMobile Card fits easily into any wallet and delivers a medical-grade, single-lead ECG in 30 seconds.

Frequently Asked Questions About This Report

The prominent players operating in the global cardiopulmonary stress testing devices market are GE Healthcare; Koninklijke Philips N V; Nihon Kohden Corporation; Thermo Fisher Scientific, Inc.; CareFusion Corporation (Becton, Dickinson and Company); CAIRE Inc.; Cardinal Health, Inc.; Hill-Rom Holdings Inc.; OSI Systems Inc; Schiller AG; COSMED Srl; and Welch Allyn, Inc.

The increasing incidence of cardiovascular diseases, rising awareness about early diagnosis and treatment of heart diseases, and the increasing demand for technologically advanced cardiopulmonary stress testing devices are some of the driving factors of the global market

The Cardiopulmonary exercise testing (CPET) systems segment holds the largest market share of the cardiopulmonary stress testing devices market

The expensive cost of the equipment, the requirement for qualified operators, and the meagre reimbursement are some of the obstacles for the market for cardiopulmonary stress testing devices

The global cardiopulmonary stress testing devices market size is estimated at US$ 8.49 billion in 2030

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecast Years – 2022 to 2030
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021) 
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL CARDIOPULMONARY STRESS TESTING DEVICES MARKET - ANALYSIS & FORECAST, BY PRODUCT TYPE 
    1. Cardiopulmonary Exercise Testing (CPET) Systems
    2. Stress ECG
    3. Stress Blood Pressure Monitors
    4. Pulse Oximeters
    5. Single-Photon Emission Computed Tomography (SPECT)
  6. GLOBAL CARDIOPULMONARY STRESS TESTING DEVICES MARKET - ANALYSIS & FORECAST, BY END-USER
    1. Hospitals
    2. Specialty Clinics
    3. Diagnostic Centers
    4. Others
  7. GLOBAL CARDIOPULMONARY STRESS TESTING DEVICES MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Cardiopulmonary Stress Testing Devices Market
      1. North America Cardiopulmonary Stress Testing Devices Market, by Product Type
      2. North America Cardiopulmonary Stress Testing Devices Market, by End User
      3. North America Cardiopulmonary Stress Testing Devices Market, by Country
        1. U.S.
          1. U.S. Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. U.S. Cardiopulmonary Stress Testing Devices Market, by End User
        2. Canada
          1. Canada Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. Canada Cardiopulmonary Stress Testing Devices Market, by End User
    2. Europe Cardiopulmonary Stress Testing Devices Market
      1. Europe Cardiopulmonary Stress Testing Devices Market, by Product Type
      2. Europe Cardiopulmonary Stress Testing Devices Market, by End User
      3. Europe Cardiopulmonary Stress Testing Devices Market, by Country/Region
        1. Germany
          1. Germany Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. Germany Cardiopulmonary Stress Testing Devices Market, by End User
        2. U.K.
          1. U.K. Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. U.K. Cardiopulmonary Stress Testing Devices Market, by End User
        3. France
          1. France Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. France Cardiopulmonary Stress Testing Devices Market, by End User
        4. Spain
          1. Spain Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. Spain Cardiopulmonary Stress Testing Devices Market, by End User
        5. Italy
          1. Italy Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. Italy Cardiopulmonary Stress Testing Devices Market, by End User
        6. Rest of Europe 
          1. Rest of Europe Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. Rest of Europe Cardiopulmonary Stress Testing Devices Market, by End User
    3. Asia Pacific Cardiopulmonary Stress Testing Devices Market
      1. Asia Pacific Cardiopulmonary Stress Testing Devices Market, by Product Type
      2. Asia Pacific Cardiopulmonary Stress Testing Devices Market, by End User
      3. Asia Pacific Cardiopulmonary Stress Testing Devices Market, by Country/Region
        1. China
          1. China Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. China Cardiopulmonary Stress Testing Devices Market, by End User
        2. Japan
          1. Japan Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. Japan Cardiopulmonary Stress Testing Devices Market, by End User
        3. India
          1. India Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. India Cardiopulmonary Stress Testing Devices Market, by End User
        4. South Korea
          1. South Korea Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. South Korea Cardiopulmonary Stress Testing Devices Market, by End User
        5. Australia
          1. Australia Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. Australia Cardiopulmonary Stress Testing Devices Market, by End User
        6. Rest of Asia Pacific
          1. Rest of Asia Pacific Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. Rest of Asia Pacific Cardiopulmonary Stress Testing Devices Market, by End User
    4. Rest of the World Cardiopulmonary Stress Testing Devices Market
      1. Rest of the World Cardiopulmonary Stress Testing Devices Market, by Product Type
      2. Rest of the World Cardiopulmonary Stress Testing Devices Market, by End User
      3. Rest of the World Cardiopulmonary Stress Testing Devices Market, by Region
        1. Latin America
          1. Latin America Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. Latin America Cardiopulmonary Stress Testing Devices Market, by End User
        2. Middle East & Africa
          1. Middle East & Africa Cardiopulmonary Stress Testing Devices Market, by Product Type
          2. Middle East & Africa Cardiopulmonary Stress Testing Devices Market, by End User
  8. COMPANY PROFILES
    1. GE Healthcare
      1. Business Snapshot
      2. Products Offered
      3. Financial Details*
      4. Strategic Development
    2. Koninklijke Philips N V
    3. Nihon Kohden Corporation
    4. Thermo Fisher Scientific, Inc.
    5. CareFusion Corporation (Becton, Dickinson and Company)
    6. CAIRE Inc.
    7. Cardinal Health, Inc.
    8. Hill-Rom Holdings Inc.
    9. OSI Systems Inc.
    10. Schiller AG
    11. COSMED Srl
    12. Welch Allyn, Inc.

*Insights on financial performance are subject to the availability of information in the public domain

List of Tables

  1. Global Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million)
  2. Global Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  3. Global Cardiopulmonary Stress Testing Devices Market, by Region, 2020-2030 (US$ Million) 
  4. North America Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  5. North America Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million)
  6. North America Cardiopulmonary Stress Testing Devices Market, by Country, 2020-2030 (US$ Million) 
  7. U.S. Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  8. U.S. Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  9. Canada Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  10. Canada Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  11. Europe Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  12. Europe Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  13. Europe Cardiopulmonary Stress Testing Devices Market, by Country/ Region, 2020-2030 (US$ Million) 
  14. Germany Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  15. Germany Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  16. U.K. Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  17. U.K. Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  18. France Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  19. France Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  20. Italy Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  21. Italy Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  22. Spain Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  23. Spain Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  24. Rest of Europe Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  25. Rest of Europe Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  26. Asia Pacific Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  27. Asia Pacific Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  28. Asia Pacific Cardiopulmonary Stress Testing Devices Market, by Country/ Region, 2020-2030 (US$ Million) 
  29. China Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  30. China Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  31. Japan Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  32. Japan Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  33. India Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  34. India Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  35. South Korea Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  36. South Korea Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  37. Australia Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  38. Australia Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  39. Rest of Asia Pacific Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  40. Rest of Asia Pacific Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  41. Rest of the World Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  42. Rest of the World Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  43. Rest of the World Cardiopulmonary Stress Testing Devices Market, by Region, 2020-2030 (US$ Million) 
  44. Latin America Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  45. Latin America Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 
  46. Middle East and Africa Cardiopulmonary Stress Testing Devices Market, by Product Type, 2020-2030 (US$ Million) 
  47. Middle East and Africa Cardiopulmonary Stress Testing Devices Market, by End User, 2020–2030 (US$ Million) 

List of Figures

  1. Cardiopulmonary Stress Testing Devices Market Ecosystem  
  2. Snapshot of Global Cardiopulmonary Stress Testing Devices Market, 2020-2030 
  3. Snapshot of Global Cardiopulmonary Stress Testing Devices Market, by Region, 2020-2030 
  4. Global Cardiopulmonary Stress Testing Devices Market: COVID-19 Pandemic Impact Assessment 
  5. Global Cardiopulmonary Stress Testing Devices Market: Key Players & Competitive Positioning (2021) 
  6. Cardiopulmonary Stress Testing Devices: Market Dynamics 
  7. Global Cardiopulmonary Stress Testing Devices Market for Cardiopulmonary Exercise Testing (CPET) Systems, 2020-2030 (US$ Million) 
  8. Global Cardiopulmonary Stress Testing Devices Market for Stress ECG, 2020-2030 (US$ Million) 
  9. Global Cardiopulmonary Stress Testing Devices Market for Stress Blood Pressure Monitors, 2020-2030 (US$ Million) 
  10. Global Cardiopulmonary Stress Testing Devices Market for Pulse Oximeters, 2020-2030 (US$ Million) 
  11. Global Cardiopulmonary Stress Testing Devices Market for Single-Photon Emission Computed Tomography (SPECT), 2020-2030 (US$ Million)
  12. Global Cardiopulmonary Stress Testing Devices Market for Hospitals, 2020-2030 (US$ Million) 
  13. Global Cardiopulmonary Stress Testing Devices Market for Specialty Clinics, 2020-2030 (US$ Million) 
  14. Global Cardiopulmonary Stress Testing Devices Market for Diagnostic Centers, 2020-2030 (US$ Million) 
  15. Global Cardiopulmonary Stress Testing Devices Market for Others, 2020-2030 (US$ Million) 
  16. North America Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  17. U.S. Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  18. Canada Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  19. Europe Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  20. Germany Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  21. U.K. Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  22. France Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  23. Italy Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  24. Spain Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  25. Rest of Europe Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  26. Asia Pacific Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  27. China Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  28. Japan Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  29. India Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  30. South Korea Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  31. Australia Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  32. Rest of Asia Pacific Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  33. Rest of the World Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  34. Latin America Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  35. Middle East & Africa Cardiopulmonary Stress Testing Devices Market, 2020-2030 (US$ Million) 
  36. GE Healthcare Revenue from 2018-2021 (US$ Million)
  37. Koninklijke Philips N V Revenue from 2018-2021 (US$ Million)
  38. Nihon Kohden Corporation Revenue from 2018-2021 (US$ Million)
  39. Thermo Fisher Scientific, Inc. Revenue from 2018-2021 (US$ Million)
  40. CareFusion Corporation (Becton, Dickinson and Company) Revenue from 2018-2021 (US$ Million)
  41. CAIRE Inc. Revenue from 2018-2021 (US$ Million)
  42. Cardinal Health, Inc. Revenue from 2018-2021 (US$ Million)
  43. Hill-Rom Holdings Inc. Revenue from 2018-2021 (US$ Million)
  44. OSI Systems Inc. Revenue from 2018-2021 (US$ Million)
  45. Schiller AG Revenue from 2018-2021 (US$ Million)
  46. COSMED Srl Revenue from 2018-2021 (US$ Million)
  47. Welch Allyn, Inc. Revenue from 2018-2021 (US$ Million)

Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.

Using the fundamental research and knowledge services capabilities of GRG Health, Growth Plus Reports may now be tailored based on client needs.

GRG Health's unique GrowthMIX strategy and comprehensive research methodology enable us to provide unique and valuable insights to our clients while uncovering trends that would not be discovered using traditional techniques.

sans

Snehal Deshmukh

Principle Consultant

Speak to analyst